Know what to do when a prescribed device is subject of FDA warning letter
The Food & Drug Administration (FDA) recently issued a warning letter to iRhythm Technologies about the Zio AT, one of the manufacturer’s mobile cardiac monitoring devices. However, an FDA warning letter is cause for alertness, not alarm, on the part of providers.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.